Folgen
Scott Miners
Scott Miners
Bestätigte E-Mail-Adresse bei bristol.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease
JS Miners, S Baig, J Palmer, LE Palmer, PG Kehoe, S Love
Brain pathology 18 (2), 240-252, 2008
4692008
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
JS Miners, N Barua, PG Kehoe, S Gill, S Love
Journal of Neuropathology & Experimental Neurology 70 (11), 944-959, 2011
3162011
Cerebrovascular disease in ageing and Alzheimer’s disease
S Love, JS Miners
Acta neuropathologica 131, 645-658, 2016
3002016
Cognitive impact of COVID-19: looking beyond the short term
S Miners, PG Kehoe, S Love
Alzheimer's research & therapy 12 (1), 170, 2020
2542020
Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
PG Kehoe, S Wong, N Al Mulhim, LE Palmer, JS Miners
Alzheimer's research & therapy 8, 1-10, 2016
2042016
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia
T Thomas, S Miners, S Love
Brain 138 (4), 1059-1069, 2015
1992015
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
JS Miners, Z Van Helmond, K Chalmers, G Wilcock, S Love, PG Kehoe
Journal of Neuropathology & Experimental Neurology 65 (10), 1012-1021, 2006
1902006
Angiotensins in Alzheimer's disease–friend or foe?
PG Kehoe, S Miners, S Love
Trends in neurosciences 32 (12), 619-628, 2009
1892009
Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes
S Miners, E Ashby, S Baig, R Harrison, H Tayler, E Speedy, JA Prince, ...
American journal of translational research 1 (2), 163, 2009
1872009
Angiotensin‐converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE‐1 to cerebral amyloid angiopathy
JS Miners, E Ashby, Z Van Helmond, KA Chalmers, LE Palmer, S Love, ...
Neuropathology and applied neurobiology 34 (2), 181-193, 2008
1842008
Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in …
JS Miners, I Schulz, S Love
Journal of Cerebral Blood Flow & Metabolism 38 (1), 103-115, 2018
1712018
Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity
JS Miners, S Baig, H Tayler, PG Kehoe, S Love
Journal of Neuropathology & Experimental Neurology 68 (8), 902-914, 2009
1492009
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
CE Evans, JS Miners, G Piva, CL Willis, DM Heard, EJ Kidd, MA Good, ...
Acta Neuropathologica 139 (3), 485-502, 2020
1162020
Changes with age in the activities of β‐secretase and the Aβ‐degrading enzymes neprilysin, insulin‐degrading enzyme and angiotensin‐converting enzyme
JS Miners, Z Van Helmond, PG Kehoe, S Love
Brain Pathology 20 (4), 794-802, 2010
1092010
Pathophysiology of Hypoperfusion of the Precuneus in Early A lzheimer's Disease
JS Miners, JC Palmer, S Love
Brain Pathology 26 (4), 533-541, 2016
1052016
Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
S Love, S Miners, J Palmer, K Chalmers, P Kehoe
Front Biosci 14, 4778-4792, 2009
992009
Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors
IG Goodfellow, DJ Evans, AM Blom, D Kerrigan, JS Miners, BP Morgan, ...
Journal of virology 79 (18), 12016-12024, 2005
932005
Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
M Swirski, JS Miners, R de Silva, T Lashley, H Ling, J Holton, T Revesz, ...
Alzheimer's research & therapy 6, 1-17, 2014
912014
CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
JS Miners, PG Kehoe, S Love, H Zetterberg, K Blennow
Alzheimer's research & therapy 11, 1-6, 2019
902019
BIN1 is decreased in sporadic but not familial Alzheimer’s disease or in aging
EBC Glennon, IJ Whitehouse, JS Miners, PG Kehoe, S Love, KAB Kellett, ...
PloS one 8 (10), e78806, 2013
842013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20